2021 Q1 Form 10-K Financial Statement

#000104016121000005 Filed on March 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 2019 Q4
Revenue $9.270M $40.86M $16.02M
YoY Change -32.7% -40.58% -21.99%
Cost Of Revenue $5.545M $20.67M $8.720M
YoY Change -20.77% -39.67% -9.36%
Gross Profit $3.725M $20.19M $7.300M
YoY Change -45.02% -41.48% -33.06%
Gross Profit Margin 40.18% 49.41% 45.56%
Selling, General & Admin $4.854M $19.84M $5.400M
YoY Change -6.53% -6.42% 3.65%
% of Gross Profit 130.31% 98.29% 73.97%
Research & Development $6.785M $25.04M $6.720M
YoY Change 8.27% -3.76% 0.75%
% of Gross Profit 182.15% 124.05% 92.05%
Depreciation & Amortization $1.330M $3.737M $1.390M
YoY Change -4.32% -2.61% 8.59%
% of Gross Profit 35.7% 18.51% 19.04%
Operating Expenses $11.64M $46.92M $12.20M
YoY Change -3.43% -1.46% 1.84%
Operating Profit -$7.914M -$26.74M -$4.898M
YoY Change 49.97% 103.73% 225.02%
Interest Expense $14.00K $239.0K $320.0K
YoY Change -65.0% 51.27% 255.56%
% of Operating Profit
Other Income/Expense, Net $56.00K $805.0K
YoY Change 3.7% -82.11%
Pretax Income -$7.858M -$25.93M -$4.574M
YoY Change 50.45% 61.34% 222.79%
Income Tax $217.0K $598.0K -$120.0K
% Of Pretax Income
Net Earnings -$8.075M -$26.53M -$4.456M
YoY Change 49.56% 192.27% 203.34%
Net Earnings / Revenue -87.11% -64.93% -27.81%
Basic Earnings Per Share -$0.16 -$0.65 -$0.12
Diluted Earnings Per Share -$0.16 -$0.65 -$0.12
COMMON SHARES
Basic Shares Outstanding 52.21M shares 40.71M shares 38.32M shares
Diluted Shares Outstanding 40.71M shares

Balance Sheet

Concept 2021 Q1 2020 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.40M $31.50M $14.20M
YoY Change 24.51% 121.83% -40.83%
Cash & Equivalents $25.44M $31.30M $7.257M
Short-Term Investments $0.00 $300.0K $7.000M
Other Short-Term Assets $1.900M $1.000M $1.700M
YoY Change -9.52% -41.18% 13.33%
Inventory $1.670M $2.400M $5.401M
Prepaid Expenses
Receivables $5.522M $4.700M $10.92M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $34.55M $39.60M $32.24M
YoY Change -3.69% 22.98% -9.05%
LONG-TERM ASSETS
Property, Plant & Equipment $4.384M $11.70M $4.608M
YoY Change -17.03% 17.0% -25.09%
Goodwill $18.41M $18.41M
YoY Change 0.0% 0.0%
Intangibles $902.0K $2.704M
YoY Change -61.27% -35.74%
Long-Term Investments
YoY Change
Other Assets $1.005M $1.100M $1.267M
YoY Change -25.83% -15.38% 11.93%
Total Long-Term Assets $31.32M $32.40M $32.42M
YoY Change -10.17% -0.31% 8.44%
TOTAL ASSETS
Total Short-Term Assets $34.55M $39.60M $32.24M
Total Long-Term Assets $31.32M $32.40M $32.42M
Total Assets $65.88M $72.00M $64.66M
YoY Change -6.88% 11.28% -1.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.726M $1.000M $818.0K
YoY Change -24.86% 25.0% -61.34%
Accrued Expenses $8.523M $7.200M $8.692M
YoY Change -9.45% 9.09% -15.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.40M $10.60M $9.674M
YoY Change -39.04% 9.28% -23.43%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $8.200M $8.600M $7.500M
YoY Change -12.77% 14.67% 127.27%
Total Long-Term Liabilities $8.200M $8.600M $7.500M
YoY Change -12.77% 14.67% 127.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.40M $10.60M $9.674M
Total Long-Term Liabilities $8.200M $8.600M $7.500M
Total Liabilities $18.59M $19.20M $17.13M
YoY Change -29.79% 12.28% 7.38%
SHAREHOLDERS EQUITY
Retained Earnings -$423.2M -$388.6M
YoY Change 7.41% 2.39%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $47.29M $52.90M $47.53M
YoY Change
Total Liabilities & Shareholders Equity $65.88M $72.00M $64.66M
YoY Change -6.88% 11.28% -1.05%

Cashflow Statement

Concept 2021 Q1 2020 2019 Q4
OPERATING ACTIVITIES
Net Income -$8.075M -$26.53M -$4.456M
YoY Change 49.56% 192.27% 203.34%
Depreciation, Depletion And Amortization $1.330M $3.737M $1.390M
YoY Change -4.32% -2.61% 8.59%
Cash From Operating Activities -$6.651M -$3.711M -$7.430M
YoY Change -839.0% -64.25% -1090.67%
INVESTING ACTIVITIES
Capital Expenditures $243.0K $2.637M -$400.0K
YoY Change 19.12% 0.3% 8.11%
Acquisitions
YoY Change
Other Investing Activities $250.0K $0.00 -$280.0K
YoY Change -100.0% -1500.0%
Cash From Investing Activities $7.000K $3.940M -$670.0K
YoY Change -99.84% -7825.49% 97.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $12.74M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $824.0K $23.77M -240.0K
YoY Change -84.97% -9385.55% -52.94%
NET CHANGE
Cash From Operating Activities -$6.651M -$3.711M -7.430M
Cash From Investing Activities $7.000K $3.940M -670.0K
Cash From Financing Activities $824.0K $23.77M -240.0K
Net Change In Cash -$5.820M $24.00M -8.340M
YoY Change -154.51% -324.57% 8240.0%
FREE CASH FLOW
Cash From Operating Activities -$6.651M -$3.711M -$7.430M
Capital Expenditures $243.0K $2.637M -$400.0K
Free Cash Flow -$6.894M -$6.348M -$7.030M
YoY Change -1090.52% -51.2% -727.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001040161
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 pxlw Years Of Amortization Period Of Licensed Technology Lower Limit
YearsOfAmortizationPeriodOfLicensedTechnologyLowerLimit
P2Y
CY2019Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity File Number
EntityFileNumber
000-30269
CY2020 dei Entity Registrant Name
EntityRegistrantName
PIXELWORKS, INC
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
OR
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-1761992
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
226 Airport Parkway, Suite 595
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95110
CY2020 dei City Area Code
CityAreaCode
408
CY2020 dei Local Phone Number
LocalPhoneNumber
200-9200
CY2020 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2020 dei Trading Symbol
TradingSymbol
PXLW
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Public Float
EntityPublicFloat
115004218 USD
CY2020Q2 pxlw Publicfloatshareprice
Publicfloatshareprice
3.23
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
52212421 shares
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31257000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7257000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
250000 USD
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
6975000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4672000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10915000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
2445000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
5401000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1010000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1689000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
39634000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
32237000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5103000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4608000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6606000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5434000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1081000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1267000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1207000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2704000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
18407000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
18407000 USD
CY2020Q4 us-gaap Assets
Assets
72038000 USD
CY2019Q4 us-gaap Assets
Assets
64657000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
995000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
818000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9452000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8692000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
147000 USD
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
164000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10594000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9674000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
1007000 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
982000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5088000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4212000 USD
CY2020Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
2479000 USD
CY2019Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
2260000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
19168000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
17128000 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51078942 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51078942 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38434488 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38434488 shares
CY2020Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
467957000 USD
CY2019Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
436122000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
47000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-415134000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-388605000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
52870000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
47529000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
72038000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
64657000 USD
CY2020 us-gaap Revenues
Revenues
40855000 USD
CY2019 us-gaap Revenues
Revenues
68755000 USD
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20670000 USD
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
34260000 USD
CY2020 us-gaap Gross Profit
GrossProfit
20185000 USD
CY2019 us-gaap Gross Profit
GrossProfit
34495000 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25040000 USD
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26018000 USD
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19840000 USD
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21202000 USD
CY2020 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
2041000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
46921000 USD
CY2019 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
398000 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
47618000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-26736000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-13123000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000 USD
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
594000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
796000 USD
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0 USD
CY2019 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
3905000 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
805000 USD
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4499000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-25931000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8624000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
598000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
453000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-26529000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-9077000 USD
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.65
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40712000 shares
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37851000 shares
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-26529000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-9077000 USD
CY2020 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-48000 USD
CY2019 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
7000 USD
CY2020 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-3000 USD
CY2019 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
3000 USD
CY2020 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-10000 USD
CY2019 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
1000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26494000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9080000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-26529000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-9077000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
7853000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
6649000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3737000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3837000 USD
CY2020 pxlw Amortization Of Acquired Intangible Assets
AmortizationOfAcquiredIntangibleAssets
1496000 USD
CY2019 pxlw Amortization Of Acquired Intangible Assets
AmortizationOfAcquiredIntangibleAssets
1504000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
796000 USD
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020 pxlw Reversal Of Uncertain Tax Positions
ReversalOfUncertainTaxPositions
88000 USD
CY2019 pxlw Reversal Of Uncertain Tax Positions
ReversalOfUncertainTaxPositions
124000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
26000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
45000 USD
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
4000 USD
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
94000 USD
CY2020 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
4000 USD
CY2019 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
0 USD
CY2020 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0 USD
CY2019 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
3905000 USD
CY2020 pxlw Amortizationof Intangible Assetsand Inventory Fair Value Adjustment
AmortizationofIntangibleAssetsandInventoryFairValueAdjustment
0 USD
CY2019 pxlw Amortizationof Intangible Assetsand Inventory Fair Value Adjustment
AmortizationofIntangibleAssetsandInventoryFairValueAdjustment
12000 USD
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-9000 USD
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3000 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6243000 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3933000 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2956000 USD
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2459000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3295000 USD
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2172000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
166000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1304000 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2361000 USD
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3686000 USD
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
290000 USD
CY2019 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-14000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3711000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2629000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10380000 USD
CY2020 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
8229000 USD
CY2019 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
10050000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2637000 USD
CY2020 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1500000 USD
CY2019 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
10856000 USD
CY2020 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
152000 USD
CY2019 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
521000 USD
CY2020 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
0 USD
CY2019 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
4250000 USD
CY2020 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2019 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
345000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3940000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51000 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12743000 USD
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2020 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6210000 USD
CY2019 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
CY2020 pxlw Proceeds From Issuance Of At The Market Offering
ProceedsFromIssuanceOfAtTheMarketOffering
4429000 USD
CY2019 pxlw Proceeds From Issuance Of At The Market Offering
ProceedsFromIssuanceOfAtTheMarketOffering
0 USD
CY2020 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
1007000 USD
CY2019 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
826000 USD
CY2020 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
796000 USD
CY2019 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
0 USD
CY2020 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
600000 USD
CY2019 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
570000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23771000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-256000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24000000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10687000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7257000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17944000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31257000 USD
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
23832000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7257000 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
397000 USD
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
547000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
217000 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
142000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
796000 USD
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020 pxlw Fixed Asset And Other Asset Expenses Incurred But Not Yet Paid
FixedAssetAndOtherAssetExpensesIncurredButNotYetPaid
1495000 USD
CY2019 pxlw Fixed Asset And Other Asset Expenses Incurred But Not Yet Paid
FixedAssetAndOtherAssetExpensesIncurredButNotYetPaid
934000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
49390000 USD
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
570000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
6649000 USD
CY2019 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-9077000 USD
CY2019 pxlw Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentTaxPortionAttributableToParent
-1000 USD
CY2019 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
6000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
47529000 USD
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
600000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
7853000 USD
CY2020 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-3000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-26529000 USD
CY2020 pxlw Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentTaxPortionAttributableToParent
10000 USD
CY2020 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-38000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
52870000 USD
CY2020Q4 pxlw Number Of Patents
NumberOfPatents
338 patent
CY2020 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-419000 USD
CY2019 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-270000 USD
CY2020 us-gaap Use Of Estimates
UseOfEstimates
The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles ("U.S. GAAP") requires us to make estimates and judgments that affect amounts reported in the financial statements and accompanying notes. Our significant estimates and judgments include those related to revenue recognition, valuation of excess and obsolete inventory, lives and recoverability of equipment and other long-lived assets, valuation of goodwill, stock-based compensation and income taxes. The actual results experienced could differ materially from our estimates.
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1307000 USD
CY2020 pxlw Years Of Amortization Period Of Licensed Technology Upper Limit
YearsOfAmortizationPeriodOfLicensedTechnologyUpperLimit
P5Y
CY2020 us-gaap Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
If there is an indicator of impairment, we prepare an estimate of future, undiscounted cash flows expected to result from the use of each asset and its eventual disposition. If these cash flows are less than the carrying value of the asset, we adjust the carrying amount of the asset to its estimated fair value.
CY2020Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
4713000 USD
CY2019Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
10938000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
41000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4672000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10915000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23000 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
21000 USD
CY2020 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
18000 USD
CY2019 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
2000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
41000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1775000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1630000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
670000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3771000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
2445000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
5401000 USD
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
95000 USD
CY2019 us-gaap Inventory Write Down
InventoryWriteDown
137000 USD
CY2020 pxlw Sale Of Previously Reserved Inventory
SaleOfPreviouslyReservedInventory
29000 USD
CY2019 pxlw Sale Of Previously Reserved Inventory
SaleOfPreviouslyReservedInventory
35000 USD
CY2020Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
8889000 USD
CY2019Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
8494000 USD
CY2020Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
6298000 USD
CY2019Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
6552000 USD
CY2020Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
5711000 USD
CY2019Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
6428000 USD
CY2020Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1393000 USD
CY2019Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1392000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22291000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22866000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17188000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18258000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5103000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4608000 USD
CY2020 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1174000 USD
CY2019 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1320000 USD
CY2020 us-gaap Depreciation
Depreciation
2227000 USD
CY2019 us-gaap Depreciation
Depreciation
2300000 USD
CY2020 pxlw Amortizationoflicensedtechnology
Amortizationoflicensedtechnology
336000 USD
CY2019 pxlw Amortizationoflicensedtechnology
Amortizationoflicensedtechnology
217000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6730000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6730000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5523000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4026000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1207000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2704000 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1496000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1117000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
90000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1207000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2867000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3440000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2039000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1545000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
786000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
483000 USD
CY2020Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
630000 USD
CY2019Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
66000 USD
CY2020Q4 pxlw Accrued Commissionsand Royalties Current
AccruedCommissionsandRoyaltiesCurrent
474000 USD
CY2019Q4 pxlw Accrued Commissionsand Royalties Current
AccruedCommissionsandRoyaltiesCurrent
663000 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
429000 USD
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
397000 USD
CY2020Q4 us-gaap Deferred Revenue
DeferredRevenue
179000 USD
CY2020Q4 pxlw Line Of Credit Facility Maximum Borrowing Capacity Under Non Formula Advances
LineOfCreditFacilityMaximumBorrowingCapacityUnderNonFormulaAdvances
10000000 USD
CY2019Q4 us-gaap Deferred Revenue
DeferredRevenue
146000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2048000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1952000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9452000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8692000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
146000 USD
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
96000 USD
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
935000 USD
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
511000 USD
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
902000 USD
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
461000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
179000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
146000 USD
CY2020Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
10000000 USD
CY2020Q4 pxlw Line Of Credit Facility Component Of Calculation For Maximum Borrowing Amount Under Formula Advances
LineOfCreditFacilityComponentOfCalculationForMaximumBorrowingAmountUnderFormulaAdvances
2500000 USD
CY2020Q4 pxlw Line Of Credit Facility Maximum Borrowing Capacity Limited By Eligible Ar
LineOfCreditFacilityMaximumBorrowingCapacityLimitedByEligibleAr
0.80
CY2020 pxlw Line Of Credit Facility Interest Rate Prime Rate Plus
LineOfCreditFacilityInterestRatePrimeRatePlus
0.0025
CY2020Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
253000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
-3000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
250000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
6972000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
3000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
6975000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
364000 USD
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
66000 USD
CY2020 us-gaap Restructuring Charges
RestructuringCharges
2214000 USD
CY2020 us-gaap Payments For Restructuring
PaymentsForRestructuring
1650000 USD
CY2020Q4 us-gaap Restructuring Reserve
RestructuringReserve
630000 USD
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
2721000 USD
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
2496000 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
2816000 USD
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
2697000 USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3535000 USD
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1440000 USD
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M3D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y11M19D
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0499
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0549
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2353000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2475000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1342000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
877000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
364000 USD
CY2020Q4 pxlw Lessee Operating Lease Liability Payments Due Year Seven
LesseeOperatingLeaseLiabilityPaymentsDueYearSeven
91000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7866000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
739000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
7127000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40855000 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
68755000 USD
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
150000 USD
CY2020 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
which we expect to recognize ratably over the next 15 months.
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-341000 USD
CY2020 us-gaap Other Income
OtherIncome
161000 USD
CY2019 us-gaap Other Income
OtherIncome
425000 USD
CY2020 us-gaap Interest And Other Income
InterestAndOtherIncome
87000 USD
CY2019 us-gaap Interest And Other Income
InterestAndOtherIncome
327000 USD
CY2020 us-gaap Interest Expense
InterestExpense
239000 USD
CY2019 us-gaap Interest Expense
InterestExpense
158000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000 USD
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
594000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-25590000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-16072000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
7448000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-25931000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8624000 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-74000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-103000 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000 USD
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
643000 USD
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
509000 USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
572000 USD
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
408000 USD
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
26000 USD
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
45000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
26000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
45000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
598000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
453000 USD
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 pxlw Income Tax Reconciliation Income Tax Expense Benefit Expiration Of Tax Attributes
IncomeTaxReconciliationIncomeTaxExpenseBenefitExpirationOfTaxAttributes
-0.14
CY2019 pxlw Income Tax Reconciliation Income Tax Expense Benefit Expiration Of Tax Attributes
IncomeTaxReconciliationIncomeTaxExpenseBenefitExpirationOfTaxAttributes
-0.38
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.07
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.25
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.01
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.03
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.01
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.07
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.02
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.05
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.31
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
0.01
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.02
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.05
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
65772000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
67648000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
50917000 USD
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
47779000 USD
CY2020Q4 pxlw Deferred Tax Assets Property And Equipment
DeferredTaxAssetsPropertyAndEquipment
2282000 USD
CY2019Q4 pxlw Deferred Tax Assets Property And Equipment
DeferredTaxAssetsPropertyAndEquipment
1956000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1158000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1134000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
275000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
719000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
145000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1785000 USD
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2074000 USD
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1434000 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
122623000 USD
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
122455000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
1526000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
1300000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1526000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1300000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
120981000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
121005000 USD
CY2019 us-gaap Royalty Expense
RoyaltyExpense
521000 USD
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
150000 USD
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
24000 USD
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2667000 USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
116000 USD
CY2020Q4 pxlw Operating Loss Carryforwards Carried Forward Indefinetly
OperatingLossCarryforwardsCarriedForwardIndefinetly
32258000 USD
CY2020Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1610000 USD
CY2020 pxlw Reductiontodeferredtaxassets
Reductiontodeferredtaxassets
1189000 USD
CY2019Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1554000 USD
CY2019 pxlw Reductiontodeferredtaxassets
Reductiontodeferredtaxassets
1100000 USD
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
18000 USD
CY2019 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
30000 USD
CY2020Q4 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
13000 USD
CY2020 us-gaap Royalty Expense
RoyaltyExpense
242000 USD
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
48 USD
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
62 USD
CY2020Q4 pxlw Software Licenses Future Minimum Payments Due Next Twelve Months
SoftwareLicensesFutureMinimumPaymentsDueNextTwelveMonths
829000 USD
CY2020Q4 pxlw Software Licenses Future Minimum Payments Due In Two Years
SoftwareLicensesFutureMinimumPaymentsDueInTwoYears
679000 USD
CY2020Q4 pxlw Software Licenses Future Minimum Payments Due In Three Years
SoftwareLicensesFutureMinimumPaymentsDueInThreeYears
99000 USD
CY2020Q4 pxlw Software Licenses Future Minimum Payments Due Total
SoftwareLicensesFutureMinimumPaymentsDueTotal
1607000 USD
CY2020Q4 pxlw Software Licenses Future Minimum Payments Due Interest Component
SoftwareLicensesFutureMinimumPaymentsDueInterestComponent
107000 USD
CY2020Q4 pxlw Software Licenses Future Minimum Payments Due Present Value
SoftwareLicensesFutureMinimumPaymentsDuePresentValue
1500000 USD
CY2020Q4 pxlw Software Licenses Future Minimum Payments Due Current Portion Of Present Value
SoftwareLicensesFutureMinimumPaymentsDueCurrentPortionOfPresentValue
786000 USD
CY2020Q4 pxlw Software Licenses Future Minimum Payments Due Long Term Portion Of Present Value
SoftwareLicensesFutureMinimumPaymentsDueLongTermPortionOfPresentValue
714000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-26529000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-9077000 USD
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40712000 shares
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37851000 shares
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.65
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
19683333 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1566811 shares
CY2009Q2 pxlw Share Based Compensation Arrangement By Share Based Payment Award Options Percent Vested On One Year Anniversary Of Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPercentVestedOnOneYearAnniversaryOfGrant
0.25
CY2009Q2 pxlw Share Based Compensation Arrangement By Share Based Payment Award Options Monthly Vesting Percent Vesting Beginning After Year One
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMonthlyVestingPercentVestingBeginningAfterYearOne
0.02083
CY2009Q2 pxlw Share Based Compensation Arrangement By Share Based Payment Award Options Number Of Months Vesting After One Year
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNumberOfMonthsVestingAfterOneYear
36
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
533484 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.87
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
234000 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.00
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
25563 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.74
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4896 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.98
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
17958 shares
CY2020 pxlw Share Based Compensation Arrangements By Share Based Payment Award Options Expired Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpiredWeightedAverageExercisePrice
5.16
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
719067 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.53
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
28000 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
256000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
323000 USD
CY2020Q4 pxlw Share Based Compensation Arrangement By Share Based Payment Award Options Vested
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVested
458650 shares
CY2020Q4 pxlw Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice
2.70
CY2020 pxlw Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTerm
P1Y3M18D
CY2020Q4 pxlw Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue
131000 USD
CY2020Q4 pxlw Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVest
244024 shares
CY2020Q4 pxlw Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice
2.22
CY2020 pxlw Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm
P5Y7M20D
CY2020Q4 pxlw Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue
180000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
702674 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.54
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P2Y9M21D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
311000 USD
CY2020 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
2137317 shares
CY2019 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
1917514 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.42
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.81
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3112426 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.06
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
2137817 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.42
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1834406 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
3.93
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
239232 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
4.28
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3176605 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.68
CY2020Q4 pxlw Share Based Compensation Arrangement By Share Based Payment Restricted Stock Unit Awards Outstanding Expected To Vest
ShareBasedCompensationArrangementByShareBasedPaymentRestrictedStockUnitAwardsOutstandingExpectedToVest
2947031 shares
CY2020Q4 pxlw Share Based Compensation Arrangement By Share Based Payment Restricted Stock Unit Awards Outstanding Expected To Vest Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentRestrictedStockUnitAwardsOutstandingExpectedToVestWeightedAverageExercisePrice
3.68
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.93
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.23
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5391000 USD
CY2020 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M2D
CY2020 us-gaap Revenues
Revenues
40855000 USD
CY2019 us-gaap Revenues
Revenues
68755000 USD
CY2020Q1 us-gaap Revenues
Revenues
13774000 USD
CY2020Q2 us-gaap Revenues
Revenues
9253000 USD
CY2020Q3 us-gaap Revenues
Revenues
8190000 USD
CY2020Q4 us-gaap Revenues
Revenues
9638000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2020Q3 us-gaap Gross Profit
GrossProfit
3976000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
6775000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
5049000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
4385000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5277000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6421000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8137000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-6901000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5223000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6445000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8165000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6098000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-5399000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-6552000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-8139000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-6439000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2217000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2019Q1 us-gaap Revenues
Revenues
16648000 USD
CY2019Q2 us-gaap Revenues
Revenues
18027000 USD
CY2019Q3 us-gaap Revenues
Revenues
18057000 USD
CY2019Q4 us-gaap Revenues
Revenues
16023000 USD
CY2019Q1 us-gaap Gross Profit
GrossProfit
8472000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
9376000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
9347000 USD
CY2019Q4 us-gaap Gross Profit
GrossProfit
7300000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3460000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2321000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2444000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4898000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
541000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2374000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4574000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
133000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-2448000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2306000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-4456000 USD
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12

Files In Submission

Name View Source Status
0001040161-21-000005-index-headers.html Edgar Link pending
0001040161-21-000005-index.html Edgar Link pending
0001040161-21-000005.txt Edgar Link pending
0001040161-21-000005-xbrl.zip Edgar Link pending
ex1036svblocamendmentdec20.htm Edgar Link pending
ex1039privateplacement-sec.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pxlw-20201231.htm Edgar Link pending
pxlw-20201231.xsd Edgar Link pending
pxlw-20201231_cal.xml Edgar Link unprocessable
pxlw-20201231_def.xml Edgar Link unprocessable
pxlw-20201231_htm.xml Edgar Link completed
pxlw-20201231_lab.xml Edgar Link unprocessable
pxlw-20201231_pre.xml Edgar Link unprocessable
pxlw12312020_ex231.htm Edgar Link pending
pxlw12312020_ex232.htm Edgar Link pending
pxlw12312020_ex311.htm Edgar Link pending
pxlw12312020_ex312.htm Edgar Link pending
pxlw12312020_ex321.htm Edgar Link pending
pxlw12312020_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending